As treatment continued, there is a significant decrease in the number of EMPs, indicating reduced endothelial damage and improved vascular repair processes ( Moreover, intermittent fasting (IF), as a metabolic intervention strategy, has been extensively studied and has been shown to significantly improve body weight, lipid profiles, and blood pressure, thereby reducing the risk of CVDs (Kazeminasab et al., 2024)
So they make that clarification there, right
What the clinical data shows From the Phase 2 trial: Two patterns stand out
Significant weight loss typically begins within the first month, with clinical studies showing average weight loss of 15-20% over 6-12 months with consistent treatment and lifestyle modifications
These compounds each bring unique benefits to different areas of health and wellness